Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 15.85
0.00 (0.00%)
At close: Mar 2, 2026
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 405.97 million as of March 2, 2026. Its market cap has increased by 68.67% in one year.
Market Cap
405.97M
Enterprise Value
385.42M
Revenue
8.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.85
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 405.97M, an increase of 314.41%. That is a compound annual growth rate of 14.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 405.97M | 15.19% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 660.10M |
| FluoGuide | 585.31M |
| Oncopeptides AB | 463.60M |
| Ascelia Pharma AB | 397.73M |
| Lipum AB | 307.58M |
| Elicera Therapeutics AB | 303.35M |
| Bio-Works Technologies AB | 291.31M |
| Mendus AB | 285.89M |